{
    "nct_id": "NCT04085367",
    "official_title": "A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis (AK) of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT)",
    "inclusion_criteria": "* Participants aged â‰¥ 18 years at the Screening visit.\n* Participants had at least 4, but no more than 12, clinically-confirmed thin or moderately thick, non-hyperkeratotic, non-pigmented AKs located on the face (e.g., forehead, cheek, chin), and balding scalp.\n* Female Participants of non-childbearing potential.\n* Participants fully understood and signed an ICF before any investigational procedure(s) are performed.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants with pigmented AK in the treatment areas.\n* Female participants who were pregnant, nursing, or planning a pregnancy during the study.\n* Participants with a clinical diagnosis of a skin disease other than AK.\n* Immunocompromised participants.\n* Participants with any condition that may be associated with a risk of poor protocol compliance.",
    "miscellaneous_criteria": ""
}